More frequent lab tests will be recommended for patients taking Arava (leflunomide)

More frequent lab tests will be recommended for patients taking Arava (leflunomide).

This is due to potential hepatotoxicity or severe infections due to immunosuppression.

The biggest concern is for patients with other risk factors for hepatotoxicity or immunosuppression.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote